| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/23/2001 | EP1100527A2 Receptor ligand antagonist complexes and their use in treating or preventing receptor mediated diseases |
| 05/23/2001 | EP1100522A1 Pulmonary delivery of active agents |
| 05/23/2001 | EP1100519A1 Multibinding agents that modulate nmda receptors |
| 05/23/2001 | EP1100499A1 Prevention of migraine recurrence |
| 05/23/2001 | EP1100494A1 Pharmaceutically composition comprising an aqueous solution of paclitaxel and albumin |
| 05/23/2001 | EP1100491A1 Ophthalmic compositions for treating ocular hypertension |
| 05/23/2001 | EP1100478A1 Estradiol-containing patch for transdermal administration of hormones |
| 05/23/2001 | EP1100476A1 Formulations for the transdermal administration of fenoldopam |
| 05/23/2001 | EP1100475A1 Use of drug-loaded nanoparticles for the treatment of cancers |
| 05/23/2001 | EP1100474A2 Two-piece capsule for receiving pharmaceutical preparations for powder inhalers |
| 05/23/2001 | EP1100473A2 Absorbable brachytherapy and chemotherapy delivery devices and methods |
| 05/23/2001 | EP1100472A1 Pharmaceutical compositions comprising ibuprofen and domperidone |
| 05/23/2001 | EP1100471A1 Compressed compositions comprising clarified xanthan gum |
| 05/23/2001 | EP1100469A1 Rapidly disintegrable solid preparation |
| 05/23/2001 | EP1100468A1 Microparticles with adsorbent surfaces, methods of making same, and uses thereof |
| 05/23/2001 | EP1100467A1 Method for making coated gabapentine or pregabaline particles |
| 05/23/2001 | EP1100465A1 Medicinal aerosol formulations |
| 05/23/2001 | EP1100464A1 Lipid emulsion and solid lipid nanoparticle as a gene or drug carrier |
| 05/23/2001 | EP1100463A1 New injectable formulations containing ramoplanin |
| 05/23/2001 | EP1100460A1 A moldable solid delivery system |
| 05/23/2001 | EP1100459A1 Foaming oil preparation and its use |
| 05/23/2001 | EP1100451A1 Topical moisture regulating compositions |
| 05/23/2001 | EP1100433A1 Finely dispersed emulsifier-free systems of the oil-in-water and water-in-oil type, containing boron nitride |
| 05/23/2001 | EP1100431A1 Finely dispersed emulsifier-free systems of the oil-in-water and water-in-oil type |
| 05/23/2001 | EP1100344A1 Novel chitosan-containing liquid compositions and methods for their preparation and use |
| 05/23/2001 | EP0850262B1 Selectively functionalizable desdendrimers |
| 05/23/2001 | DE19962221A1 Sustained-release medicament formulation, e.g. for parenteral or transdermal use, comprising drug and carrier system consisting of solid biodegradable blood plasma proteins obtained by fluidized bed drying |
| 05/23/2001 | DE19956029A1 Active substance carrier system based on coating a substance with enzymatically cleavable side groups, useful for gene therapy especially of cancer and inflammation |
| 05/23/2001 | DE19951474A1 Celluloseether stabilisierte Öl-in-Wasser Emulsionen als Träger für homöopatische und pflanzliche Wirkstoffe Cellulose stabilized oil-in-water emulsions as carriers for homeopathic and herbal remedies |
| 05/23/2001 | CN1296418A Controlled release tablet produced from linear water-insoluble polysaccharides |
| 05/23/2001 | CN1296416A Adjuvant compositions |
| 05/23/2001 | CN1296412A Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants |
| 05/23/2001 | CN1296407A Device for the transdermal delivery of dicolfenac |
| 05/23/2001 | CN1296406A Pharmaceutial compositions |
| 05/23/2001 | CN1296404A Agents promoting laminin production in skin cells |
| 05/23/2001 | CN1066065C Interferon solution |
| 05/23/2001 | CN1066027C Composition containing water soluble beta-caroten |
| 05/22/2001 | US6235781 Prostaglandin product |
| 05/22/2001 | US6235733 Aids therapy |
| 05/22/2001 | US6235726 Preventing tissue adhesion |
| 05/22/2001 | US6235725 Methods and compositions for the prevention of tolerance to medications |
| 05/22/2001 | US6235724 Injections containing lipid a analogues and process for the preparation thereof |
| 05/22/2001 | US6235721 Oxidation resistance |
| 05/22/2001 | US6235712 Non-aqueous polar aprotic peptide formulations |
| 05/22/2001 | US6235314 Analgesic, anti-inflammatory and skeletal muscle relaxant compositions |
| 05/22/2001 | US6235311 Pharmaceutical composition containing a combination of a statin and aspirin and method |
| 05/22/2001 | US6235282 Vaccinal fluid water-in-oil emulsions containing a metabolizable oil |
| 05/22/2001 | US6235258 High surface area silica solid |
| 05/21/2001 | WO2001044307A2 Degradable poly(vinyl alcohol) hydrogels |
| 05/21/2001 | CA2391618A1 Degradable poly(vinyl alcohol) hydrogels |
| 05/17/2001 | WO2001034801A2 Recombinant gelatin in vaccines |
| 05/17/2001 | WO2001034792A2 Compositions and methods for the diminution or elimination of various cancers |
| 05/17/2001 | WO2001034709A1 Dye labeled imidazoquinoline compounds |
| 05/17/2001 | WO2001034700A1 Composition for hydrogel, hydrogel, and use thereof |
| 05/17/2001 | WO2001034677A1 Swelling and deswelling polymer blends |
| 05/17/2001 | WO2001034651A1 Antibodies binding a non naturally occurring enantiomer (l-biotin) and their use as targeting agents |
| 05/17/2001 | WO2001034647A2 Animal collagens and gelatins |
| 05/17/2001 | WO2001034646A2 Recombinant gelatins |
| 05/17/2001 | WO2001034617A2 Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors |
| 05/17/2001 | WO2001034607A1 Pdgf receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same |
| 05/17/2001 | WO2001034591A2 Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 05/17/2001 | WO2001034554A1 Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders |
| 05/17/2001 | WO2001034549A1 Hydroxyeicosatetraenoate salts, compositions and methods of use in treating dry eye disorders |
| 05/17/2001 | WO2001034207A1 Gene carriers |
| 05/17/2001 | WO2001034206A2 Nucleic acid-containing complex |
| 05/17/2001 | WO2001034205A2 Use of lytic toxins and toxin conjugates |
| 05/17/2001 | WO2001034185A2 Induction of mucosal immunity by vaccination via the skin route |
| 05/17/2001 | WO2001034182A2 Composition for treating respiratory tract infections containing menthol, eucalyptol and an alpha-amylase |
| 05/17/2001 | WO2001034174A2 Methods for administration of therapeutic agents on an antiangiogenic schedule |
| 05/17/2001 | WO2001034166A1 Transplant/implant device and method for its production |
| 05/17/2001 | WO2001034165A1 Therapeutic compositions and methods of use thereof |
| 05/17/2001 | WO2001034140A1 Pharmaceutical formulation |
| 05/17/2001 | WO2001034130A1 Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes |
| 05/17/2001 | WO2001034122A1 Film coating method for tablets |
| 05/17/2001 | WO2001034121A2 Multi-layer preparation in film form, consisting of hydrophilic polymers, for the rapid release of active ingredients |
| 05/17/2001 | WO2001034119A2 Inhibitors of crystallization in a solid dispersion |
| 05/17/2001 | WO2001034118A2 Solid dispersion pharmaceutical formulations |
| 05/17/2001 | WO2001034117A1 A method for chemoprevention of prostate cancer |
| 05/17/2001 | WO2001034115A2 Method for encapsulating proteins or peptides in liposomes, liposomes produced using said method, and their use |
| 05/17/2001 | WO2001034113A2 Apparatus and method for preparing microparticles |
| 05/17/2001 | WO2001034112A1 Sustained-release drug formulations for implantation |
| 05/17/2001 | WO2001034099A1 Soy depigmenting and skin care compositions |
| 05/17/2001 | WO2001033975A1 Nutritional compositions which contain non-digestible polysaccharides and use thereof to reduce transport through tight junctions |
| 05/17/2001 | WO2001022992A3 Influenza vaccine |
| 05/17/2001 | WO2001021140A3 Cosmetic and/or pharmaceutical preparations |
| 05/17/2001 | WO2001019356A3 High lipid diet |
| 05/17/2001 | WO2001005427B1 Psca: prostate stem cell antigen and uses thereof |
| 05/17/2001 | WO2001001932A3 Oligosaccharide aldonic acids and their topical use |
| 05/17/2001 | WO2000078796A3 Labeled neurotensin derivatives with improved resistance to enzymatic degradation |
| 05/17/2001 | WO2000076550A3 Carrier-drug conjugate |
| 05/17/2001 | WO2000049038A9 Synthetic peptide of regulatory virus protein r (vpr) of human immunodeficiency virus type 1 (hiv-1) and the utilization thereof |
| 05/17/2001 | WO1999048536A3 Delivery of long lasting therapeutic agents by forming covalent attachments in vivo |
| 05/17/2001 | US20010001310 Bispecific antibodies for retargeting anticancer cytotoxic lymphocytes |
| 05/17/2001 | US20010001307 And mineral; for suppressing or ameliorating a symptom accompanying diminished homeostasis; having a reduced peculiar metal taste |
| 05/17/2001 | US20010001279 Stable microbubble suspensions as enhancement agents for ultrasound echography |
| 05/17/2001 | DE19954843A1 Verfahren zur Verkapselung von Proteinen oder Peptiden in Liposomen, mit dem Verfahren hergestellte Liposomen und deren Verwendung A process for the encapsulation of proteins or peptides in liposomes, liposomes produced by the method and the use thereof |
| 05/17/2001 | DE19954528A1 Eingekapseltes Aroma The encapsulated flavor |
| 05/17/2001 | DE19954394A1 Verwendung von Polysiloxanen mit quartären Aminogruppen als Formulierungshilfe und Mittel enthalten dieselben Use of polysiloxanes with quaternary amino groups as a formulation aid and medium containing the same |
| 05/17/2001 | DE19952982A1 Verfahren zur gerichteten Verpackung von molekularen Substanzen in Proteinhüllen Method for the directed packaging of molecular substances in protein shells |
| 05/17/2001 | DE19952957A1 Modulare Transportsysteme für molekulare Substanzen und deren Herstellung und Verwendung Modular Transport systems for molecular substances and their production and use |